Moneycontrol
    Moneycontrol PRO

    Jump to

    • Buy Strides Pharma; target of Rs 635: Motilal Oswal

    • Market Headstart: Nifty likely to open flat; 3 stocks which could give 7-8% return

    • Buy Strides Pharma Science; target of Rs 530: Geojit

    • Buy Strides Pharma; target of Rs 590: Motilal Oswal

    • Market Headstart: Nifty likely to open higher; 3 stocks which could give 7-10% return

    • Buy Strides Shasun; target of Rs 481: Motilal Oswal

    • Buy Strides Shasun; target of Rs 480: HDFC Securities

    • Buy Strides Shasun; target of Rs 530: JM Financial

    • Buy Strides Shasun; target of Rs 980: HDFC Securities

    • Buy Strides Shasun; target of Rs 1200: HDFC Securities

    • Buy Strides Shasun; target of Rs 1201: Motilal Oswal

    • Buy Strides Shasun; target of Rs 1300: Motilal Oswal

    • Buy Strides Shasun; target of Rs 1030: Axis Direct

    • Buy Strides Shasun; target of Rs 1,200: Axis Direct

    • Buy Strides Shasun; target of Rs 1340: Axis Direct

    • Here are Prakash Diwan's top trading ideas

    • Hold Strides Shasun; target of Rs 1190: Religare

    • Hold Strides Shasun; target of Rs 1130: Religare

    • Buy Strides Arcolab; target of Rs 1570:Religare

    • Buy Strides Arcolab; target of Rs 900: Religare Capital

    • Buy Strides Arcolab; target of Rs 1225: Way2Wealth

    • Accumulate Strides Arcolab; target Rs 917: Dolat Capital

      Dolat Capital is bullish on Strides Arcolab and has recommended accumulate rating on the stock with a target price of Rs 917 in its March 04, 2013 research report.

    • Accumulate Strides Arcolab; target 935: Dolat Capital

      Dolat Capital is bullish on Strides Arcolab and has recommended buy rating on the stock with a target of Rs 935 in its October 22, 2012 research report.

    • Buy Strides Arcolab; target of Rs 1007: ICICIdirect.com

      ICICIdirect.com is bullish on Strides Arcolab and has recommended buy rating on the stock with a target of Rs 1007 in its October 22, 2012 research report.

    • Buy Strides Arcolab; target of Rs 829: Motilal Oswal

      Motilal Oswal is bullish on Strides Arcolab and has recommended buy rating on the stock with a target of Rs 829 in its July 31, 2012 research report.

    Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347